Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ONCONOX ApS
APS
Bankrupt
Advertising protection
CVR 33858965
Kastanievej 25, 2670
Greve
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 14 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ONCONOX ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JS
Jesper Smedegaard Madsen
Founder
Founder
2011
Former (2)
BD
Bo Danner Henriksen
Management
Management
2020 – 2024
OK
Ole Kjær
Unofficial title
Unofficial title
2024 – 2026
Board of directors
Non-executive oversight
Name
Role
Member since
Former (5)
FK
Frank Knudsen
Board of Directors
Board of Directors
2013 – 2013
OB
Ole Bitsch-Jensen
Board of Directors
Board of Directors
2011 – 2013
HT
Hans Thalsgård Schambye
Chairman
Chairman
2011 – 2013
GG
Gianni Garotta
Chairman
Chairman
2013 – 2018
FN
Ferdinando Nicoletti
Chairman
Chairman
2018 – 2019
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Amme Pharmaceuticals, Inc.
Individual
100%
100%
2019
Donata Maria Cantoni
Individual
20–24.99%
20–24.99%
2018
Mai-Britt Zocca
Individual
20–24.99%
20–24.99%
2013
Yousef Alabed
Individual
20–24.99%
20–24.99%
2011
Gianni Garotta
Individual
20–24.99%
20–24.99%
2011
Ferdinando Nicoletti
Individual
100%
100%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ONCONOX ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network